[Webinar] How biotech companies can improve clinical supply planning and distribution
Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies
Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and riskRegister
Enrolling study subjects, setting up patient randomization and managing drug supply are critical to the success of a clinical trial. In today’s tech-savvy world, interactive response technology (IRT) combined with supply forecasting tools provide biotech companies with seamless solutions for the planning of supply production and distribution, managing drug supply, mitigating patient recruitment delays, improving cross-departmental communication, all while saving them time and money and reducing risks.
Join best-in-class experts from S-Clinica to discuss how IRT and supply forecasting grants sponsors the flexibility to utilize information consistently and accurately, while helping to reduce supply drug waste, inventory changes and study management.
In this webinar you will:
- Master how to optimize supply planning and distribution by using supply forecasting and IRT.
- Learn when to start supply planning and how to proceed.
- Discover how to investigate potential scenarios and what needs to be considered.
- Understand how to mitigate the impact of potential recruitment delays.
- Learn how to analyze the impact of study changes on supply management.
- Understand why a harmonization of supply forecasting and IRT is important to reduce costs and risks.
Sign up today to understand how to implement an affordable supply-forecasting tool into your clinical supply chain.
Irena Seredina, Executive Director at S-Clinica
Irena Seredina holds a Medical Doctor, honors diploma and a Master of Science degree in Health Economics. During her medical practice, Seredina worked in clinical research as an investigator. The results of her research were published in a number of articles highlighting her knowledge of the critical challenges of clinical sites and of the importance of being patient-centric. She continued her career as a health economist and in 2004, Seredina joined S-Clinica. She began her career at S-Clinical as a business developer and progressed to be the Head of Operations. She is currently responsible for customer relationships and strategic business.
Matthew Konneh, Vice President of Strategic Alliances
Matthew Konneh, holds a PhD and MBA in Cardiovascular Pharmacology. Konneh has worked extensively in drug development for over 20 years, initially as a researcher at Novartis and in business consulting in the pharmaceutical practice of Accenture. He has worked for a number of partner research organizations in clinical development, including Biotrial, Celerion and Parexel. Konneh is currently responsible for strategic development at Strategic Alliances and marketing at S-Clinica.
The webinar will take place at:
- 7am PDT
- 10am EDT
- 2pm GMT
- 4pm CET